[Vaccination against diphtheria and tetanus of children with thymus hyperplasia syndrome].
Inhibition of cellular and humoral immunity was established in children with grade I thymus enlargement syndrome (TES). The most pronounced changes were recorded in children aged 1-5 years. Vaccination against diphtheria and tetanus performed before the diagnosis of the TES was made were followed by satisfactory output of anatoxins, indicating the prospectiveness of the vaccination of the given children's group with DPT vaccine and DT- and DT-M-anatoxin.
Ozeretskovskiĭ
N A
NA
Martynova
M I
MI
Shishatskaia
S N
SN
Kova'lskaia
S Ia
SIa
Veĭsfeĭler
O Iu
OIu
Vaganov
P D
PD
Mikheeva
I G
IG
D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004165:Diphtheria / Q000517:prevention & control*; D004168:Diphtheria Toxoid / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007223:Infant; D013742:Tetanus / Q000517:prevention & control*; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000276:immunology*; D013952:Thymus Hyperplasia / Q000276:immunology*
D004168:Diphtheria Toxoid; D013745:Tetanus Toxoid
O vaktsinatsii protiv difterii i stolbniaka deteĭ s sindromom uvelicheniia vilochkovoĭ zhelezy.